Michael B. Atkins - Director at Werewolf Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
HOWL on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Michael B. Atkins since 7/8/2023

Holdings reported by Michael B. Atkins for Werewolf Therapeutics, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 14,419 $31.9 K $2.21 Jan 4, 2024 Direct
Stock Option (right to buy) 6,723 May 24, 2024 Direct Common Stock

Transactions reported by Michael B. Atkins for Werewolf Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership